amikacin has been researched along with daptomycin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanberger, H | 1 |
Kuechle, DK; Landon, GC; Musher, DM; Noble, PC | 1 |
Van der Auwera, P | 1 |
Bumgardner, JD; Courtney, H; Haggard, WO; Noel, SP | 1 |
Baietto, L; D'Avolio, A; De Rosa, FG; Di Perri, G; Garazzino, S; Michelazzo, M; Sciandra, M; Siccardi, M; Simiele, M; Ventimiglia, G | 1 |
Bowler, IC; Collier, J; Colston, JM; Scarborough, M | 1 |
Courtney, HS; Haggard, WO; Jennings, JA; Moshref, AR; Smith, JK | 1 |
1 trial(s) available for amikacin and daptomycin
Article | Year |
---|---|
Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Corynebacterium; Daptomycin; Drug Therapy, Combination; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1989 |
6 other study(ies) available for amikacin and daptomycin
Article | Year |
---|---|
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin | 1992 |
Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement.
Topics: Amikacin; Anti-Bacterial Agents; Atmospheric Pressure; Bacteria; Bone Cements; Daptomycin; Dextrans; Diffusion; Methylmethacrylates; Peptides; Porosity; Vancomycin | 1991 |
Chitosan films: a potential local drug delivery system for antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Biocompatible Materials; Chitosan; Daptomycin; Drug Carriers; Nephelometry and Turbidimetry; Permeability; Spectrophotometry; Staphylococcus aureus | 2008 |
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Daptomycin; Gentamicins; Humans; Limit of Detection; Rifampin | 2010 |
High-dose daptomycin monotherapy cures Staphylococcus epidermidis 'endotipsitis' after failure of conventional therapy.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Catheters; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Male; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Failure; Vancomycin | 2013 |
Chitosan sponges for local synergistic infection therapy: a pilot study.
Topics: Amikacin; Anti-Infective Agents; Chitosan; Daptomycin; Drug Delivery Systems; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pilot Projects; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |